Identifying Broad-Spectrum Influenza Virus Inhibitors
Identifying Broad-Spectrum Influenza Virus Inhibitors
批准号:
6832579
负责人:
Fang Fang
金额:
$44.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2006-05-31
关键词:
MDCK cellOrthomyxoviridaeSDS polyacrylamide gel electrophoresisantiviral agentschick embryocysteine endopeptidasesdisease /disorder prevention /controldisease outbreaksdrug discovery /isolationdrug quality /standarddrug screening /evaluationelectroporationenzyme linked immunosorbent assayhemagglutination testimmunoprecipitationinfluenzapeptide librarypharmacokineticspolymerase chain reactionprotease inhibitorserine proteinasessubtilisinstissue /cell culturetrypsin inhibitors
中文摘要
描述(由申请人提供):急需流感的广谱治疗药物来解决流感大流行问题,这是全球公共卫生的主要威胁。我们已经提出了旨在鉴定能够通过靶向激活所有流感病毒所必需的宿主因子来阻断所有流感病毒株感染的分子的研究。在这项拟议的I期研究中,我们将产生候选药物,表征并比较它们的体外生化和功能活性。我们的目标是确定两种最终候选药物,并准备在II期研究中进行进一步的临床前评价。
英文摘要
DESCRIPTION (provided by applicant): Broad-spectrum therapeutics for influenza is critically needed to address the problem of influenza pandemics, a major threat to the public health globally. We have proposed studies aiming at identifying molecules that are capable of blocking infections of all strains of influenza viruses by targeting the host factors which are essential for activation of all influenza viruses. In this proposed phase I study, we will generate the drug candidates, charactering and compare their biochemical and functional activities in vitro. Our goal is to have two final candidates identified and ready for further preclinical evaluation in phase II study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden
-
批准号:10662424
-
项目类别:
-
资助金额:$49.37万
-
财政年份:2021
-
负责人:Fang Fang
-
依托单位:
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden
-
批准号:10378842
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2021
-
负责人:Fang Fang
-
依托单位:
Identifying blood-based DNA methylation biomarkers of cannabis use
-
批准号:10452701
-
项目类别:
-
资助金额:$52.33万
-
财政年份:2020
-
负责人:Fang Fang
-
依托单位:
Identifying blood-based DNA methylation biomarkers of cannabis use
-
批准号:10669580
-
项目类别:
-
资助金额:$49.07万
-
财政年份:2020
-
负责人:Fang Fang
-
依托单位:
Identifying blood-based DNA methylation biomarkers of cannabis use
-
批准号:10268978
-
项目类别:
-
资助金额:$57.29万
-
财政年份:2020
-
负责人:Fang Fang
-
依托单位:
Proof-of-Principle Studies of DAS181 for Parainfluenza Virus Infection
-
批准号:7804815
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2010
-
负责人:Fang Fang
-
依托单位:
Novel Therapeutics for Pandemic and Epidemic Flu
-
批准号:6789170
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2004
-
负责人:Fang Fang
-
依托单位:
A Novel Therapeutics for Pandemic & Epidemic Flu
-
批准号:6946426
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2004
-
负责人:Fang Fang
-
依托单位:
Identifying Broad-Spectrum Influenza Virus Inhibitors
-
批准号:6898717
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2004
-
负责人:Fang Fang
-
依托单位:
Development of ColdSol TMfor Rhinovirus Infections
-
批准号:6549536
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2001
-
负责人:Fang Fang
-
依托单位:
Tetravalent Humanized Anti-ICAM for Rhinovirus Infection
-
批准号:6443442
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2001
-
负责人:Fang Fang
-
依托单位:
Affinity Enhancement of a Humanized Anti-ICAM Antibody
-
批准号:6404100
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2001
-
负责人:Fang Fang
-
依托单位: